About HCi VioCare (OTCMKTS:VICA)
HCi Viocare, formerly China Northern Medical Device, Inc., is a start-up enterprise. The Company is engaged in the research and development and marketing of medical technologies, and the operation of prosthetics and orthotics (P&O) and diabetic foot total rehabilitation clinics. It is also engaged in the technology development and licensing of bioengineering innovations for the health, sports and wellness sectors. It was formed to sell medical devices with an emphasis on portable medical devices designed for home treatments with the initial focus in the northern regions of China. It intends to seek strategic relationships with medical device manufacturers both in China and North America with the aim to be their sales and distribution agent in Northern China and to assist Chinese medical device manufacturers on the development of the North American market. Its subsidiaries include HCi Viocare Technologies Limited, HCi Viocare Clinics UK Limited and HCi Viocare Clinics (Hellas) S.A.
Industry, Sector and Symbol
Industry Medical Appliances & Equipment
Trailing P/E Ratio-3.8
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on Assets-507.05%
HCi VioCare (OTCMKTS:VICA) Frequently Asked Questions
What is HCi VioCare's stock symbol?
HCi VioCare trades on the OTCMKTS under the ticker symbol "VICA."
Who are some of HCi VioCare's key competitors?
Some companies that are related to HCi VioCare include Heat Biologics (HTBX), Omega Diagnostics Group (ODX), Biopharmx (BPMX), Evgen Pharma (EVG), SenesTech (SNES), Cytori Therapeutics (CYTX), Argos Therapeutics (ARGS), Precipio (PRPO), Immune Pharmaceuticals (IMNP), Amedica (AMDA), Concepta (CPT), Ampliphi Biosciences (APHB), OpGen (OPGN), ValiRx (VAL), Alliqua Biomedical (ALQA), Proteome Sciences (PRM), Ixico (IXI) and Bioblast Pharma (ORPN).
Who are HCi VioCare's key executives?
HCi VioCare's management team includes the folowing people:
- Sotirios Leontaritis, Chief Executive Officer, Chief Financial Officer, Treasurer, Director (Age 54)
- Nicolaos Kardaras, Secretary, Director (Age 64)
- Christos Kapatos, Director (Age 37)
- Yannis Levantis, Director
How do I buy HCi VioCare stock?
Shares of HCi VioCare can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is HCi VioCare's stock price today?
One share of HCi VioCare stock can currently be purchased for approximately $0.04.
How big of a company is HCi VioCare?
HCi VioCare has a market capitalization of $7.67 million.
How can I contact HCi VioCare?
HCi VioCare's mailing address is Kintyre Hse, 209 Govan Road, GLASGOW, G51 1HJ, United Kingdom. The company can be reached via phone at +44-141-3700321.
MarketBeat Community Rating for HCi VioCare (VICA)MarketBeat's community ratings are surveys of what our community members think about HCi VioCare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
HCi VioCare (OTCMKTS:VICA) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for HCi VioCare (OTCMKTS:VICA)
No earnings announcements for this company have been tracked by MarketBeat.com
HCi VioCare (OTCMKTS:VICA) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for HCi VioCare (OTCMKTS:VICA)
No dividend announcements for this company have been tracked by MarketBeat.com
HCi VioCare (OTCMKTS VICA) Insider Trading and Institutional Ownership History
HCi VioCare (OTCMKTS VICA) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|4/16/2014||Sotirios Leontaritis||CEO||Sell||724,560||$0.80||$579,648.00|| |
|4/3/2014||Sotirios Leontaritis||CEO||Sell||200,000||$1.00||$200,000.00|| |
HCi VioCare (OTCMKTS VICA) News Headlines
No headlines for this company have been tracked by MarketBeat.com
HCi VioCare (OTCMKTS:VICA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
HCi VioCare (OTCMKTS VICA) Stock Chart for Wednesday, January, 17, 2018